142 related articles for article (PubMed ID: 38101414)
21. FOXA1 is a key determinant of estrogen receptor function and endocrine response.
Hurtado A; Holmes KA; Ross-Innes CS; Schmidt D; Carroll JS
Nat Genet; 2011 Jan; 43(1):27-33. PubMed ID: 21151129
[TBL] [Abstract][Full Text] [Related]
22. Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer.
Helminen L; Huttunen J; Tulonen M; Aaltonen N; Niskanen EA; Palvimo JJ; Paakinaho V
Nucleic Acids Res; 2024 Jan; 52(2):625-642. PubMed ID: 38015476
[TBL] [Abstract][Full Text] [Related]
23. Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer.
Gao S; Chen S; Han D; Wang Z; Li M; Han W; Besschetnova A; Liu M; Zhou F; Barrett D; Luong MP; Owiredu J; Liang Y; Ahmed M; Petricca J; Patalano S; Macoska JA; Corey E; Chen S; Balk SP; He HH; Cai C
Nat Genet; 2020 Oct; 52(10):1011-1017. PubMed ID: 32868907
[TBL] [Abstract][Full Text] [Related]
24. High-throughput RNA FISH analysis by imaging flow cytometry reveals that pioneer factor Foxa1 reduces transcriptional stochasticity.
Lalmansingh AS; Arora K; Demarco RA; Hager GL; Nagaich AK
PLoS One; 2013; 8(9):e76043. PubMed ID: 24073287
[TBL] [Abstract][Full Text] [Related]
25. PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer.
Magnani L; Ballantyne EB; Zhang X; Lupien M
PLoS Genet; 2011 Nov; 7(11):e1002368. PubMed ID: 22125492
[TBL] [Abstract][Full Text] [Related]
26. Nuclear mobility and activity of FOXA1 with androgen receptor are regulated by SUMOylation.
Sutinen P; Rahkama V; Rytinki M; Palvimo JJ
Mol Endocrinol; 2014 Oct; 28(10):1719-28. PubMed ID: 25127374
[TBL] [Abstract][Full Text] [Related]
27. Regulation of Polyhomeotic Condensates by Intrinsically Disordered Sequences That Affect Chromatin Binding.
Kapur I; Boulier EL; Francis NJ
Epigenomes; 2022 Nov; 6(4):. PubMed ID: 36412795
[TBL] [Abstract][Full Text] [Related]
28. FoxA1 binding to the MMTV LTR modulates chromatin structure and transcription.
Holmqvist PH; Belikov S; Zaret KS; Wrange O
Exp Cell Res; 2005 Apr; 304(2):593-603. PubMed ID: 15748903
[TBL] [Abstract][Full Text] [Related]
29. Analyses of an epigenetic switch involved in the activation of pioneer factor FOXA1 leading to the prognostic value of estrogen receptor and FOXA1 co-expression in breast cancer.
Jing X; Liang H; Hao C; Hongxia L; Cui X
Aging (Albany NY); 2019 Sep; 11(18):7442-7456. PubMed ID: 31562808
[TBL] [Abstract][Full Text] [Related]
30. Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors.
Hankey W; Chen Z; Wang Q
Cancer Res; 2020 Jun; 80(12):2427-2436. PubMed ID: 32094298
[TBL] [Abstract][Full Text] [Related]
31. Genetic variations of DNA bindings of FOXA1 and co-factors in breast cancer susceptibility.
Wen W; Chen Z; Bao J; Long Q; Shu XO; Zheng W; Guo X
Nat Commun; 2021 Sep; 12(1):5318. PubMed ID: 34518541
[TBL] [Abstract][Full Text] [Related]
32. Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.
Chen D; Parker TM; Bhat-Nakshatri P; Chu X; Liu Y; Wang Y; Nakshatri H
Oncogene; 2021 Feb; 40(7):1332-1346. PubMed ID: 33420376
[TBL] [Abstract][Full Text] [Related]
33. The FOXA1 transcriptional network coordinates key functions of primary human airway epithelial cells.
Paranjapye A; Mutolo MJ; Ebron JS; Leir SH; Harris A
Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L126-L136. PubMed ID: 32432922
[TBL] [Abstract][Full Text] [Related]
34. FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer.
Gong C; Fujino K; Monteiro LJ; Gomes AR; Drost R; Davidson-Smith H; Takeda S; Khoo US; Jonkers J; Sproul D; Lam EW
Oncogene; 2015 Sep; 34(39):5012-24. PubMed ID: 25531315
[TBL] [Abstract][Full Text] [Related]
35. Identification of the O-GalNAcylation site(s) on FOXA1 catalyzed by ppGalNAc-T2 enzyme in vitro.
Zhang S; Bai L; Chen Q; Ren Y; Zhang K; Wu Q; Huang H; Li W; Zhang Y; Zhang J; Liu Y
Biochem Biophys Res Commun; 2019 Jun; 514(1):157-165. PubMed ID: 31029427
[TBL] [Abstract][Full Text] [Related]
36. FOXA1 defines cancer cell specificity.
Zhang G; Zhao Y; Liu Y; Kao LP; Wang X; Skerry B; Li Z
Sci Adv; 2016 Mar; 2(3):e1501473. PubMed ID: 27034986
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive Genomic Analysis Reveals that the Pioneering Function of FOXA1 Is Independent of Hormonal Signaling.
Glont SE; Chernukhin I; Carroll JS
Cell Rep; 2019 Mar; 26(10):2558-2565.e3. PubMed ID: 30840881
[TBL] [Abstract][Full Text] [Related]
38. FOXA1 and breast cancer risk.
Meyer KB; Carroll JS
Nat Genet; 2012 Nov; 44(11):1176-7. PubMed ID: 23104063
[TBL] [Abstract][Full Text] [Related]
39. Pioneer of prostate cancer: past, present and the future of FOXA1.
Teng M; Zhou S; Cai C; Lupien M; He HH
Protein Cell; 2021 Jan; 12(1):29-38. PubMed ID: 32946061
[TBL] [Abstract][Full Text] [Related]
40. Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program.
Jin HJ; Zhao JC; Wu L; Kim J; Yu J
Nat Commun; 2014 May; 5():3972. PubMed ID: 24875621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
